Diabetes: Further insights into SGLT2 inhibitors.

Fernández-Ruiz, Irene

Diabetes: Further insights into SGLT2 inhibitors. [electronic resource] - Nature reviews. Cardiology 01 2018 - 2-3 p. digital

Publication Type: Journal Article; Comment

1759-5010

10.1038/nrcardio.2017.198 doi


Canagliflozin
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Humans
Hypoglycemic Agents
Secondary Prevention
Sodium-Glucose Transporter 2 Inhibitors